2021
DOI: 10.1016/j.avsg.2021.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Spontaneous Acute Aortic Thrombosis in SARS-CoV-2 Infection

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 11 publications
(14 reference statements)
0
2
0
Order By: Relevance
“…These patients are usually managed with anticoagulation therapy as a standard of care unless vascular intervention such as thromboembolectomy is required for larger occlusive thrombus in order to prevent emboli shower [1,28,29]. Although rare, these aortic thromboses have also been associated with occlusion of distal end arteries affecting organs such as the kidney and spleen [29][30][31] (Fig. 3).…”
Section: Aortic Thrombosismentioning
confidence: 99%
“…These patients are usually managed with anticoagulation therapy as a standard of care unless vascular intervention such as thromboembolectomy is required for larger occlusive thrombus in order to prevent emboli shower [1,28,29]. Although rare, these aortic thromboses have also been associated with occlusion of distal end arteries affecting organs such as the kidney and spleen [29][30][31] (Fig. 3).…”
Section: Aortic Thrombosismentioning
confidence: 99%
“…As described in the literature [1,2], COVID-19 infection burdens people with a high rate of thrombotic complications. The status of increased blood hypercoagulability, probably due to systemic hyper-inflammation and endothelial dysfunction, is associated with both venous and arterial thrombosis [3,4]. Arterial thrombosis accounts for about 4% of thromboembolic complications during COVID-19.…”
Section: Introductionmentioning
confidence: 99%